← Eichor
Condition: Cns Medulloblastoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cns Medulloblastoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Phase 2 · 24 location(s) · Giselle Sholler · NCT04696029Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refra
EARLY_Phase 1 · 1 location(s) · Children's National Research Institute · NCT07017816Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT06779487Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients
Phase 1 · 1 location(s) · University of Florida · NCT06514898International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT02417324Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Phase 1 · 1 location(s) · Children's National Research Institute · NCT06193759Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Phase 1 · 2 location(s) · Emory University · NCT06624371Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma
Phase N/A · 1 location(s) · West China Hospital · NCT07660458Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
Phase 3 · 20 location(s) · Donald Mabbott · NCT05230758PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Phase 2 · 13 location(s) · Nationwide Children's Hospital · NCT05096481Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma
EARLY_Phase 1 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06959979PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161519GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Phase 1 · 1 location(s) · Stanford University · NCT07087002Medulloblastoma Online Video-based Exercise Pilot Study
NA · 2 location(s) · Aron Onerup · NCT06898684Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT05535166Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Phase 2 · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501718Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
Phase N/A · 2 location(s) · Mohammad H. Abu Arja · NCT07242963A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Gliobl
Phase 1 · 2 location(s) · University of Florida · NCT0457314068-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Phase 4 · 1 location(s) · Weill Medical College of Cornell University · NCT04081701Digoxin Medulloblastoma Study
Phase 2 · 15 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06701812Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliom
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT04185038Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT07584499Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05672043GD2-CAR T Cells for Pediatric Brain Tumours
Phase 1 · 1 location(s) · Bambino Gesù Hospital and Research Institute · NCT05298995A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Phase 3 · 108 location(s) · Children's Oncology Group · NCT05382338Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
NA · 8 location(s) · University of California, San Francisco · NCT05057702Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.